Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy.
OBJECTIVE
This open clinical trial examined the efficacy of treating obese patients with binge eating disorder (BED) with phentermine and fluoxetine in the setting of cognitive-behavioral therapy (CBT).


METHODS
Sixteen obese women received individual CBT along with phentermine/fluoxetine. Treatment goals included elimination of binge eating, weight loss, and reduced psychological distress. Following active treatment, patients were offered once-monthly maintenance treatment for 3 years.


RESULTS
Patients showed significant reduction in binge frequency, weight loss, and psychological distress at the end of active treatment, but regained most of the weight within 1 year. At 18-month follow-up, there was an ongoing reduction in binge eating for patients who continued maintenance.


CONCLUSIONS
Treatment produced comparable binge suppression and more weight loss than most reported studies of CBT alone. However, there is significant weight regain, particularly following medication discontinuation. This study does not support the long-term clinical utility of adding phentermine/fluoxetine to CBT for BED.
Devlin
M J
MJ
Eating Disorders Unit, New York State Psychiatric Institute, New York, New York 10032, USA. mjd5@columbia.edu
Goldfein
J A
JA
Carino
J S
JS
Wolk
S L
SL
D000328:Adult; D001067:Appetite Depressants / Q000008:administration & dosage* / Q000009:adverse effects; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage* / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D006963:Hyperphagia / Q000523:psychology / Q000628:therapy*; D008875:Middle Aged; D009765:Obesity / Q000523:psychology / Q000628:therapy*; D010645:Phentermine / Q000008:administration & dosage* / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D001067:Appetite Depressants; D005473:Fluoxetine; D010645:Phentermine; D017367:Selective Serotonin Reuptake Inhibitors